Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 33,894 | 13,963 | 13,898 | 13,925 | 26,011 |
| Gross Profit | 33,894 | 13,963 | 13,898 | 13,925 | 26,011 |
| Operating Expenses | 28,172 | 28,018 | 28,417 | 27,192 | 27,469 |
| Operating Income | 5,722 | -14,055 | -14,519 | -13,267 | -1,458 |
| Interest Expense | 815 | 833 | 827 | 805 | 831 |
| Other Income | 1,126 | 767 | 504 | 806 | 1,748 |
| Pre-tax Income | 6,033 | -14,121 | -14,842 | -13,266 | -541 |
| Net Income Continuous | 5,914 | -14,121 | -14,842 | -13,266 | -541 |
| Net Income | $5,914 | $-14,121 | $-14,842 | $-13,266 | $-541 |
| EPS Basic Total Ops | 0.63 | -1.54 | -1.61 | -1.47 | N/A |
| EPS Basic Continuous Ops | 0.66 | -1.54 | -1.63 | -1.46 | -0.06 |
| EPS Diluted Total Ops | 0.63 | -1.54 | -1.61 | -1.47 | N/A |
| EPS Diluted Continuous Ops | 0.66 | -1.54 | -1.63 | -1.46 | -0.06 |
| EBITDA(a) | $8,643 | $-11,127 | $-11,597 | $-10,382 | $1,700 |